TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
APLS

Apellis Pharmaceuticals Inc

Healthcare · Biotechnology

3.40$ -0.1% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Balance Sheet

Apellis Pharmaceuticals Inc (APLS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 1,083 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet APLS
Line item Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
– – 27 9.4 57 19 182 163 267 239 204 318 317 466 389 689 870 768 961 810 700 526 882 1,146 1,002 873 760 979 916 818 789 832 904 902 885 807 821 1,059 1,075 1,083
– – 27 25 57 19 182 163 267 239 202 311 308 451 373 672 854 742 917 774 655 475 824 1,104 960 832 720 954 893 797 766 811 860 834 789 728 756 991 1,015 1,028
– – 25 -25 52 13 176 153 254 221 176 288 289 434 352 418 317 416 566 265 271 284 640 633 604 584 552 765 616 452 351 327 360 397 411 358 371 479 468 407
– – 25 25 52 13 176 153 254 221 176 288 289 434 352 647 833 728 878 724 599 430 701 965 853 709 552 765 626 466 352 327 368 397 416 358 371 479 468 407
– – 1.3 1.8 1.8 2.2 1.3 1.8 2.0 1.4 1.5 1.8 2.0 – – – – – 25 20 21 24 80 6.3 7.5 8.1 7.7 32 128 187 206 268 309 284 272 244 229 355 366 445
– – – – – – – 6.3 8.9 15 – – – – – – – – 0.0 0.0 3.7 1.7 24 33 48 60 86 85 107 115 146 161 162 121 82 82 121 123 143 131
– – – – – – – – – – – 7.7 8.1 15 16 16 15 25 25 30 29 27 26 26 27 25 25 – – – – – – – – – – – – –
– – 3.6 6.1 33 6.9 33 34 37 43 43 94 158 327 355 430 638 662 756 758 841 583 683 684 668 565 590 567 570 586 594 565 640 665 657 643 665 658 705 668
– – 3.6 6.1 6.1 6.9 6.6 7.3 10 16 17 20 36 45 66 51 58 75 128 84 158 94 132 125 127 115 168 139 175 186 248 215 169 191 186 178 201 280 324 283
– – – – – – 26 27 27 – 1.7 1.1 1.5 2.3 2.6 2.7 2.7 3.4 3.7 3.9 4.0 4.1 4.1 4.6 5.3 5.4 5.6 5.8 5.9 5.7 6.4 90 6.2 6.8 6.8 6.9 7.4 101 101 101
– – 2.5 2.6 2.6 4.0 3.7 4.6 5.1 5.5 10 12 14 12 8.4 3.1 9.9 11 8.5 4.2 5.3 5.0 17 12 16 14 37 31 28 18 38 27 38 43 39 55 54 39 57 49
– – – – – – 26 27 27 27 25 6.7 6.7 141 143 145 349 354 359 386 386 190 189 189 189 93 93 93 93 93 93 93 457 452 453 453 454 361 362 362
– – 24 24 24 12 149 129 230 196 161 225 159 140 34 259 232 106 205 52 -141 -57 199 462 334 307 170 412 345 232 195 267 264 237 229 164 156 401 370 415
– – -98 -119 -119 -131 -149 -171 -204 -240 -277 -327 -398 -468 -581 -750 -869 -1,005 -926 -1,094 -1,313 -1,509 -1,657 -1,796 -1,952 -2,143 -2,309 -2,487 -2,609 -2,749 -2,837 -2,904 -2,942 -2,999 -3,035 -3,128 -3,170 -2,954 -3,013 -2,994
18 18 18 18 18 34 34 50 55 56 58 58 63 64 74 74 76 76 79 79 81 86 86 98 107 109 111 114 119 120 121 123 124 124 124 125 126 126 126 126

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?